Cooley advised Inscripta on the deal. Inscripta, a global leader in genome engineering technology, announced its acquisition of Infinome Biosciences and Sestina Bio. These acquisitions advance Inscripta’s…
Inscripta’s Acquisition of Infinome Biosciences and Sestina Bio
